{"id":226739,"date":"2010-01-25T13:48:55","date_gmt":"2010-01-25T18:48:55","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=59955"},"modified":"2010-01-25T13:48:55","modified_gmt":"2010-01-25T18:48:55","slug":"2009%e2%80%99s-top-10-private-equity-deals-in-massachusetts-the-list","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/226739","title":{"rendered":"2009\u2019s Top 10 Private Equity Deals in Massachusetts: The List"},"content":{"rendered":"\n
VC<\/a>, deals<\/a>, IPOs<\/a><\/div>\n

\t\t\"Top<\/a>
\n\t\tRyan McBride wrote:<\/strong><\/p>\n

Life sciences companies nabbed nine of the 10 largest private equity deals in the Boston area in 2009, a year when investors were called on to fund biotechs and medical devices companies in late stages of product development, according to a recent survey by Dow Jones VentureSource.<\/p>\n

The survey data indicate that private equity investors such as venture firms are pumping money into companies that may have considered the public markets in better times. For example, Woburn-based BioVex, which is developing a viral drug for skin cancer, closed one of the largest private financings in the Boston area last year, after scrapping plans for a $45 million initial public offering in 2006.<\/p>\n

However, lithium-ion battery maker A123Systems, based in Watertown, managed to raise big bucks in private equity in the first half of 2009 and then follow up that performance with a $380 million IPO in September<\/a>. Also, Cambridge-based cancer drug developer Aveo Pharmaceuticals, another firm that made the top-10 list, filed regulatory papers in December with the SEC to raise more than $86 million in an IPO<\/a>.<\/p>\n

You can find out more about all the companies on the list and their plans for the future by following the links below.<\/p>\n

The list:<\/p>\n

A123Systems<\/a>, Watertown, MA — $99.9 million (Series F)<\/p>\n

BioVex<\/a>, Woburn, MA — $70 million (Series F)<\/p>\n

ConforMIS<\/a>, Burlington, MA, — $50 million (Series D)<\/p>\n

Proteon Therapeutics<\/a>, Waltham, MA — $50 million (Series B)<\/p>\n

Virdante Pharmaceuticals<\/a>, Cambridge, MA — $47.75 million (Series A)<\/p>\n

Aveo Pharmaceuticals<\/a>, Cambridge, MA — $45 million (Series E)<\/p>\n

Synageva BioPharma<\/a>, Waltham, MA — $45 million (5th Round)<\/p>\n

Aileron Therapeutics<\/a>, Cambridge, MA — $40.15 million (4th Round)<\/p>\n

EpiZyme<\/a>, Cambridge, MA — $40 million (Series B)<\/p>\n

Still River Systems<\/a>, Littleton, MA — $33 million (4th Round)<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

VC, deals, IPOs Ryan McBride wrote: Life sciences companies nabbed nine of the 10 largest private equity deals in the Boston area in 2009, a year when investors were called on to fund biotechs and medical devices companies in late stages of product development, according to a recent survey by Dow Jones VentureSource. The survey […]<\/p>\n","protected":false},"author":2829,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-226739","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/226739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2829"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=226739"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/226739\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=226739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=226739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=226739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}